BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Novocure Announces 13 Preclinical Presentations Highlighting Data on Tumor Treating Fields’ Mechanism of Action at 22nd Annual Meeting of the Society for Neuro-Oncology

  In total, 60 abstracts on Tumor Treating Fields, including two oral presentations, will be presented.

  November 8, 2017

   · 

  6 min read
• Medivir Announces New Cancer Project, Leukotide, Derived From Its In-House Nucleotide Platform

  The Leukotide project is intended to deliver a new drug for the treatment of AML and other hematological malignancies, and is based on the company’s expertise in nucleoside and nucleotide science.

  November 8, 2017

   · 

  2 min read
• Deals

  CERENIS Therapeutics Acquires LYPRO Biosciences Expanding Its HDL Strategy Into Immuno-Oncology and Chemotherapeutic Drug Delivery

  Financial terms of the LYPRO Biosciences assets acquisition by CERENIS Therapeutics are not disclosed.

  November 8, 2017

   · 

  11 min read
• Drug Development

  Nordic Nanovector: Protocol Amendment Filed in the UK to Enable Initiation of Phase II PARADIGME

  Nordic Nanovector notes that information relating to an application for a Protocol Amendment to the LYMRIT 37-01 study, for the planned pivotal Phase IIb clinical trial PARADIGME to evaluate Betalutin in recurrent/relapsed follicular lymphoma has been published by MHRA.

  November 8, 2017

   · 

  2 min read
• Business

  GNS Healthcare Names Dr. David Sontag to its Strategic Advisory Board

  “David’s expertise in artificial intelligence and machine learning will be an invaluable asset to GNS’ Strategic Advisory Board,” said Colin Hill, Chairman, CEO and co-founder of GNS Healthcare.

  November 8, 2017

   · 

  3 min read
• Business

  Astrotech Reports First Quarter of Fiscal Year 2018 Financial Results

  Cash and investments at September 30, 2017 were $11.6 million, and there was no debt.

  November 8, 2017

   · 

  6 min read
• Business

  Evotec AG Announces First Nine-Month 2017 Results and Corporate Update

  In the first nine months of 2017, Evotec’s Group revenues grew to EUR 170.9 m, an increase of 42% compared to the same period of 2016 (9M 2016: EUR 120.6 m).

  November 8, 2017

   · 

  16 min read
• Business

  AccuRef Diagnostics Emerges As a New Division of Applied StemCell With a Focus on Advancing Molecular Diagnostics Through Precision Reference Standards

  The announcement comes as ARD continues to expand its product catalog to generate the largest panel of precision engineered reference standards on the market.

  November 8, 2017

   · 

  2 min read
• iVeena Delivery Systems Receives FDA Orphan Drug Designation for IVMED-80 for the Treatment of Keratoconus

  Keratoconus is a degenerative disorder causing a cornea to progressively thin and become conical in shape.

  November 8, 2017

   · 

  2 min read
• Genetown

  Amsel Medical Corporation Announces First-In-Man Clinical Use of the Amsel Occluder Device at NYU Langone Medical Center.

  AOD performance goals were met and clinical reaction was positive.

  November 8, 2017

   · 

  5 min read